Quick Answer
GUIDED THERAPEUTICS INC reported Cash and Equivalents of $2.31 million for fiscal year 2022.
GUIDED THERAPEUTICS INC Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2022 | $2.31M | +259.7% |
| 2021 | $643.0K | +253.3% |
| 2020 | $182.0K | -79.8% |
| 2019 | $899.0K | — |
| 2018 | $0.00 | -100.0% |
| 2017 | $1.0K | -92.9% |
| 2016 | $14.0K | -60.0% |
| 2015 | $35.0K | -78.4% |
| 2014 | $162.0K | -73.6% |
| 2013 | $613.0K | -41.3% |
| 2012 | $1.04M | -52.5% |
| 2011 | $2.20M | -32.7% |
| 2010 | $3.27M | +1320.9% |
| 2009 | $230.0K | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2023 | $731.0K | -72.9% | -46.2% |
| June 30, 2023 | $1.36M | +204.5% | -26.1% |
| March 31, 2023 | $1.84M | +153.4% | -20.6% |
| December 31, 2022 | $2.31M | +259.7% | -14.2% |
| September 30, 2022 | $2.70M | +398.5% | +504.7% |
| June 30, 2022 | $446.0K | -51.6% | -38.5% |
| March 31, 2022 | $725.0K | -41.9% | +12.8% |
| December 31, 2021 | $643.0K | +253.3% | +18.9% |
- GUIDED THERAPEUTICS INC showed an increase of +259.7% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2009–2022 period, GUIDED THERAPEUTICS INC’s cash and equivalents has grown by 905.7% (from $230.0 thousand to $2.31 million).
- The most recent figure is from GUIDED THERAPEUTICS INC’s fiscal year 2022 report (Form 10-K), filed with the SEC on March 30, 2023.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: